December 26, 2024 - 18:52

US stocks were set to open post-Christmas trading with a bit of a hangover as futures for major indices dipped, reflecting a cautious investor sentiment. The Dow Jones Industrial Average, S&P 500, and Nasdaq all experienced declines, indicating a potential struggle to gain momentum as the market resumes activity after the holiday season.
Market participants are closely watching upcoming jobs data, which is expected to provide insights into the health of the labor market and the broader economy. Analysts believe that this data could influence future monetary policy decisions, particularly as the Federal Reserve continues to navigate inflationary pressures.
The post-holiday trading environment typically sees lower volumes, which can lead to increased volatility. Investors are advised to remain vigilant as economic indicators begin to roll in, with many looking for signs of resilience or weakness in the current economic landscape. As the market reopens, the focus will be on how these factors will shape trading in the days ahead.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...